Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.64 |
| ▸ | PARP11 | Q9NR21 | 4/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.58 |
| ▸ | TDP2 | O95551 | 2/20 | 0.56 |
| ▸ | PGR | P06401 | 5/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4563338 | 0.90 | PARP10 (0.61) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL3987535 | 0.86 | HSD17B1 (0.62) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL1746656 | 0.84 | HSD17B1 (0.69) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL28655414 | 0.84 | HSD17B1 (0.78) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL1745161 | 0.82 | HSD17B1 (0.71) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL24842505 | 0.80 | HSD17B1 (0.54) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL13680642 | 0.80 | PARP10 (0.64) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL3989386 | 0.80 | CASP1 (0.66) | PARP10PARP11CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL31029247 | 0.80 | CASP1 (0.59) | CYP1A2CYP11B1CYP11B2HSD17B1CASP1 | |
| SCHEMBL28603 | 0.80 | CASP1 (0.59) | CYP1A2CYP11B1CYP11B2HSD17B1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1183247-B1 | POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS | AVENTIS PHARMA GMBH (DE) | 2005-05-25 | — | — | EP | disclosed |
| EP-1156805-B1 | USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR MANUFACTURING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY | AVENTIS PHARMA GMBH (DE) | 2004-08-11 | — | — | EP | disclosed |
| EP-1183247-A1 | POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS | Aventis Pharma Deutschland GmbH (DE) | 2002-03-06 | — | — | EP | disclosed |
| US-6329407-B1 | ANOREXOGENIC AGENTS | AVENTISPHARMA DEUTSCHLAND GMBH (DE) | 2001-12-11 | — | — | US | disclosed |
| EP-1156805-A2 | USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY | Aventis Pharma Deutschland GmbH (DE) | 2001-11-28 | — | — | EP | disclosed |
| US-6187801-B1 | 6-CHLORO-2-METHYL-8H-INDENO(1,2-D)-THIAZOLE HYDROCHLORIDE, FOR EXAMPLE; ADMINISTERING TO TREAT OBESITY, DIABETES; ANORECTICS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-02-13 | — | — | US | disclosed |
| WO-2000051997-A1 | POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051579-A2 | USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |